Synlett 2019; 30(12): 1474-1478
DOI: 10.1055/s-0037-1611860
letter
© Georg Thieme Verlag Stuttgart · New York

Catalytic Asymmetric Intramolecular Bromolactonization of α,β-Unsaturated Ketones

Authors

  • Shenghui Liu

    a   International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, P. R. of China   eMail: chemjxj2015@jnu.edu.cn
  • Hailong He

    b   Guangzhou Wanglaoji Pharmaceutical Company Limited, Guangzhou 510450, P. R. of China
  • Min Gan

    a   International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, P. R. of China   eMail: chemjxj2015@jnu.edu.cn
  • Peng Yi

    a   International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, P. R. of China   eMail: chemjxj2015@jnu.edu.cn
  • Xiaojian Jiang  *

    a   International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou 510632, P. R. of China   eMail: chemjxj2015@jnu.edu.cn

We thank the Natural Science Foundation of Guangdong Province (Grant No. 2017B050506006) and Fundamental Research Funds for the Central University (Grant No. 21617470) for financial support.
Weitere Informationen

Publikationsverlauf

Received: 29. April 2019

Accepted after revision: 21. Mai 2019

Publikationsdatum:
12. Juni 2019 (online)


Graphical Abstract

Preview

Abstract

Enantioselective bromolactonization by using an amino-urea catalyst to generate the important bromo-containing 3,4-dihydroisocoumarins is described. Excellent yields and good enantioselectivities could be achieved for various 3,4-dihydroisocoumarin compounds.

Supporting Information